US Patent Issued to Interius Biotherapeutics on Aug. 26 for "Pseudotyped viral particles, compositions comprising the same, and uses thereof" (Pennsylvania, Florida Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,377, issued on Aug. 26, was assigned to Interius Biotherapeutics Inc. (Philadelphia).

"Pseudotyped viral particles, compositions comprising the same, and uses thereof" was invented by Ronnie M. Russell (Philadelphia), Philip R. Johnson (Sarasota, Fla.) and Bruce Schnepp (Philadelphia).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided for herein are mutant VSV-G polypeptides, compositions comprising the same, and methods of using the same. Also provided for herein are polypeptides and compositions that bind to CD7 and uses thereof. Also provided for herein are polypeptides and compositions that bind to CD8 and uses thereof."

The patent was file...